TOP
Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.
- Pubmed_id: 37506264
- Journal: The Journal of infectious diseases
-
Genbank_id: No known Genbank_id
- Date: Feb 2024
- Volume: 229
- Issue: 2
- Pages: 413-421
-
Author(s):
Chou S,
Alain S,
Cervera C,
Chemaly RF,
Kotton CN,
Lundgren J,
Papanicolaou GA,
Pereira MR,
Wu JJ,
Murray RA,
Buss NE,
Fournier M,